SOPHiA GENETICS Statistics
Total Valuation
SOPHiA GENETICS has a market cap or net worth of $350.34 million. The enterprise value is $347.37 million.
Important Dates
The last earnings date was Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SOPHiA GENETICS has 71.79 million shares outstanding. The number of shares has increased by 3.62% in one year.
| Current Share Class | 71.79M |
| Shares Outstanding | 71.79M |
| Shares Change (YoY) | +3.62% |
| Shares Change (QoQ) | +3.86% |
| Owned by Insiders (%) | 10.52% |
| Owned by Institutions (%) | 38.58% |
| Float | 51.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.32 |
| Forward PS | 3.58 |
| PB Ratio | 7.67 |
| P/TBV Ratio | 35.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 1.37.
| Current Ratio | 2.06 |
| Quick Ratio | 1.71 |
| Debt / Equity | 1.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.98 |
Financial Efficiency
Return on equity (ROE) is -123.28% and return on invested capital (ROIC) is -40.31%.
| Return on Equity (ROE) | -123.28% |
| Return on Assets (ROA) | -29.71% |
| Return on Invested Capital (ROIC) | -40.31% |
| Return on Capital Employed (ROCE) | -65.38% |
| Weighted Average Cost of Capital (WACC) | 9.39% |
| Revenue Per Employee | $195,614 |
| Profits Per Employee | -$195,027 |
| Employee Count | 415 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 4.38 |
Taxes
In the past 12 months, SOPHiA GENETICS has paid $1.26 million in taxes.
| Income Tax | 1.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.94% in the last 52 weeks. The beta is 1.01, so SOPHiA GENETICS's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | +68.94% |
| 50-Day Moving Average | 4.94 |
| 200-Day Moving Average | 4.51 |
| Relative Strength Index (RSI) | 49.31 |
| Average Volume (20 Days) | 96,613 |
Short Selling Information
The latest short interest is 198,408, so 0.28% of the outstanding shares have been sold short.
| Short Interest | 198,408 |
| Short Previous Month | 175,963 |
| Short % of Shares Out | 0.28% |
| Short % of Float | 0.38% |
| Short Ratio (days to cover) | 2.14 |
Income Statement
In the last 12 months, SOPHiA GENETICS had revenue of $81.18 million and -$80.94 million in losses. Loss per share was -$1.18.
| Revenue | 81.18M |
| Gross Profit | 54.62M |
| Operating Income | -72.18M |
| Pretax Income | -79.67M |
| Net Income | -80.94M |
| EBITDA | -70.32M |
| EBIT | -72.18M |
| Loss Per Share | -$1.18 |
Full Income StatementBalance Sheet
The company has $65.39 million in cash and $62.43 million in debt, with a net cash position of $2.97 million or $0.04 per share.
| Cash & Cash Equivalents | 65.39M |
| Total Debt | 62.43M |
| Net Cash | 2.97M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 45.69M |
| Book Value Per Share | 0.64 |
| Working Capital | 49.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$40.26 million and capital expenditures -$1.45 million, giving a free cash flow of -$41.72 million.
| Operating Cash Flow | -40.26M |
| Capital Expenditures | -1.45M |
| Depreciation & Amortization | 1.86M |
| Net Borrowing | 32.59M |
| Free Cash Flow | -41.72M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
Gross margin is 67.28%, with operating and profit margins of -88.91% and -99.70%.
| Gross Margin | 67.28% |
| Operating Margin | -88.91% |
| Pretax Margin | -98.14% |
| Profit Margin | -99.70% |
| EBITDA Margin | -86.62% |
| EBIT Margin | -88.91% |
| FCF Margin | n/a |
Dividends & Yields
SOPHiA GENETICS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.62% |
| Shareholder Yield | -3.62% |
| Earnings Yield | -23.10% |
| FCF Yield | -11.91% |
Analyst Forecast
The average price target for SOPHiA GENETICS is $8.00, which is 61.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 61.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 25.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SOPHiA GENETICS has an Altman Z-Score of -3.98 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.98 |
| Piotroski F-Score | 2 |
